Caissa Capital Management ltd., 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 1,608,000 shares at $0.64 ($1.0M) on 2023-06-26, disclosed to the SEC on 2023-06-27.
Scheduled purchase ($1.0M) by 10% Owner.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 182,300 | $113K | 11.0% |
| 2 | $0.64 | 1,425,700 | $912K | 89.0% |
| Total | $0.64 avg | 1,608,000 | $1.0M | 100% |
| Filing → |
| AVTX | BUY | 2023-06-09 | $56K | — | Filing → |
| AVTX | BUY | 2023-06-02 | $2K | — | Filing → |
| AVTX | BUY | 2023-05-30 | $7K | — | Filing → |